Partnership advances Alzheimer's research

Image: January marks Alzheimer Awareness Month, an appropriate time to take note of the substantial contribution to research made by the Pacific Alzheimer Research Foundation through partnership with the Michael Smith Foundation for Health Research in 2015.

January marks Alzheimer Awareness Month, an appropriate time to take note of the substantial contribution to research made by the Pacific Alzheimer Research Foundation (PARF) through partnership with MSFHR in 2015.

PARF’s mission is funding scientific research and investigation into the cause, prevention and treatment of Alzheimer’s disease and related dementias. For the 2015 Trainee Program competition, PARF followed through on its commitment to support scientists working in this area by co-funding six post-doctoral Trainee awards with MSFHR.

The awards support outstanding BC researchers who ranked at the highest levels of MSFHR’s rigorous peer-review process. By co-funding these awards, both partners were able to extend the reach of their resources and foster excellence in a shared priority area.

“The primary goal is to increase the capacity and improve the quality of research into the cause and cure of Alzheimer disease and related dementias,” said Dr. Lynn Beattie, President of PARF.

Beattie added that MSFHR’s rigorous peer-review system was a key factor in the choice to invest in research through the Trainee Program, as was the co-funding agreement that extends the reach of PARF’s resources.

MSFHR and PARF look forward to continuing the partnership in 2016 by co-funding excellent Scholars and Trainees working to reduce the toll of Alzheimer’s disease.

2015 Trainees co-funded by MSFHR and the Pacific Alzheimer Research Foundation

  • Cindy Barha
    “A randomized controlled trial examining the effect of aerobic exercise on cognitive decline and brain region volumes in older men and women with mild cognitive impairment: Possible interaction between sex and BDNF polymorphisms”
  • Vedrana Cvetkovska
    “The mechanism and significance of the synaptogenic activity of amyloid precursor protein”
  • Brett Eyford
    ​“Assessment of melanotransferrin as an Alzheimer's disease biomarker”
  • Jasmin Hefendehl
    “Altered glutamate dynamics in a mouse model of Alzheimer’s disease: Novel early biomarkers with therapeutic potential”
  • Sieun Lee
    “Are there indicators of Alzheimer's disease in the eye?: New computational imaging and analysis algorithms”
  • Yun Zhang
    “Human islet amyloid polypeptide aggregation, the missing link between type 2 diabetes and Alzheimer’s disease?”